Akebia Therapeutics | AKBA - Marktkapitalisierung

Aktienkurs
1.40
Täglich Wechseln
-0.01 -0.71%
Monatlich
0%
Jährlich
-15.15%
Q2 Prognose
1.36




Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Akebia Therapeutics USD 427M 297M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
Ardelyx USD 1.42B 89M 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
Bayer EUR 36.36B 9.13B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Cspc Pharmaceutical CNY 87.29B 19.74B 2025-12
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 1.78B 215M 2025-12
Exelixis USD 11.75B 959M 2025-12
Fresenius Medical Care EUR 11.96B 1.14B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
J&J USD 500.24B 67.44B 2025-12
Kangmei Pharma CNY 27.93B 1.73B 2025-09
Karyopharm Therapeutics USD 652M 517M 2026-04
Knight Therapeutics CAD 600.53M 14.56M 2025-12
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 62.53M 563.29K 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Organigram Holdings CAD 312.16M 66.64M 2025-12
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pharma Mar EUR 1.35B 283.5M 2025-12
Prothena USD 514M 11M 2025-12
PTC Therapeutics USD 6.1B 1.22B 2025-12
Qiagen NV USD 9.9B 207.4M 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Sartorius EUR 16.41B 2.95B 2025-12
Tectonic Therapeutic USD 390M 96M 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12
Zealand Pharma A/S 33.35B 0 2026-04
Zz Pientze Pharmaceu CNY 118.73B 1.94B 2025-09